Best way to value the data is by comparing to how existing drugs performed at relevant stages of development and trials and so far IMU has outperformed them all. That's why I am so upbeat and obviously IMU as well.
For the clinical values we have to wait, financially we already know what should it be worth according to my above statement. Comparing to the current MC, it is an almost 100% safe buy imo.
GLTA
Thanks Wasa for providing **eyBabe the link.
Best way to value the data is by comparing to how existing drugs...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |